Aptamer Group reports strong FY2025 growth and expands Optimer® portfolio

Aptamer Group plc (LON:APTA), the leading developer of next-generation synthetic binders delivering innovation to the life science industry, has announced that the Annual Report and Accounts for the year ended 30 June 2025 and Notice of its 2025 Annual General Meeting (AGM) were posted to shareholders today.

APTA-Annual-Report-2025 Download

Aptamer will host its AGM at 11:00 GMT on 27 November 2025 at Windmill House, Innovation Way, York, YO10 5BR. The AGM will be held in person only and there will be no new information presented at the meeting.

The results of voting on all resolutions at the AGM will be announced to the London Stock Exchange and the full results of the voting published on the Company’s website, as soon as practicable after the conclusion of the AGM.

Share on:

You might also enjoy reading Aptamer signs contract with Metir for Cryptosporidium detection binders

Written by: Amilia Stone

Latest Company News

Aptamer and Metir advance real-time water pathogen detection programme

February 17, 2026

Aptamer Group has met Phase 1 technical objectives in its partnership with Metir, demonstrating the feasibility of integrating Optimer® binders into a continuous waterborne pathogen detection system.

Aptamer technology integrated into Twist’s new TrueAmp NGS Library Prep Kit

February 11, 2026

Aptamer Group has announced that Twist Bioscience Corporation has launched its TrueAmp Library Preparation Kit, incorporating Aptamer’s proprietary Optimer® binders to enable room-temperature stability in next-generation sequencing workflows.

Aptamer Group secures £270k in new orders and first cash licensing receipts

January 29, 2026

Aptamer Group plc has announced £190,000 in new fee-for-service Optimer® orders and £80,000 in cash licensing receipts, including its first payment from a hot-start PCR licence.